4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Effect of the PainCoach App on Pain and Opiate Use After Total Knee Replacement

Effect of the PainCoach App on Pain and Opiate Use After Total Knee Replacement

Study Description
Brief Summary:

Less is known about pain and opiate use at home directly after total knee replacement (TKR). Regarding side effects, low opiate use is desired. An e-health application, PainCoach app, was developed to guide patients in pain control and opiate use.

The aim of this study was to investigate the effect of the PainCoach app on pain and opiate use in TKR patients in the first two weeks at home after surgery. The hypothesis was that the use of this app would decrease pain and opiate use.


Condition or disease Intervention/treatment Phase
Total Knee Replacement Pain Opioid Use E-health App Behavioral: PainCoach app Not Applicable

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 97 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Patients were randomised to the PainCoach-app group or control group. Both groups received usual care. In the PainCoach-app group, in addition to receiving the aforementioned usual care, patients could use the PainCoach app whenever they wanted. In response to the patient's input of the pain experienced, the app gave advice on pain medication use, exercises/rest and when to call the clinic. This advice was the same as patients also received during usual care.
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Effect of the PainCoach App on Pain and Opiate Use in the First Two Weeks After Total Knee Replacement: Randomised Controlled Trial
Actual Study Start Date : January 15, 2016
Actual Primary Completion Date : July 6, 2016
Actual Study Completion Date : June 8, 2017
Arms and Interventions
Arm Intervention/treatment
Experimental: PainCoach-app group
In the PainCoach-app group, in addition to receiving the aforementioned usual care, the PainCoach app was downloaded on each patient's smartphone or tablet. Patients could use this app whenever they wanted until day 14 after surgery. They were not subjected to any different treatment compared to the control group, i.e. advice on pain management was delivered in an extra and different way, but the pain medication itself was exactly the same for both groups.
Behavioral: PainCoach app
In response to the patient's input of the pain experienced (no pain, bearable pain, unbearable pain, or untenable pain), the app gave advice on pain medication use, exercises/rest and when to call the clinic from day 1 until day 14 after surgery.

No Intervention: Control group
The control group received usual care.
Outcome Measures
Primary Outcome Measures :
  1. Change in pain at rest in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Pain at rest was daily measured with VAS from 0 (no pain) to 100 (worst imaginable pain)

  2. Change in pain during activity in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)

  3. Change in pain at night in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)

  4. Change in opiate use in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Oxycodon (5 mg per tablet) use was recorded in quantities per 24 hours


Secondary Outcome Measures :
  1. Pain at rest [ Time Frame: 1 month after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)

  2. Pain during activity [ Time Frame: 1 month after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)

  3. Pain at night [ Time Frame: 1 month after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)

  4. Change in other pain medication use in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    i.e. NSAID (Diclofenac), acetaminophen and/or Gabapentin were recorded in quantities per 24 hours

  5. Change in pain acceptance at rest, during activity and at night in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14, and at 1 month after surgery ]
    Measured with a happy smiley (acceptable pain) and a sad smiley (unacceptable pain)

  6. Change in experiences with the executed recommended physiotherapy exercises in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Measured on a 3-item scale; did too much, exactly enough, or could have done more exercises

  7. Function [ Time Frame: 1 month after surgery ]
    Measured with the Knee injury and Osteoarthritis Outcome Score - Physical Function Short-form (KOOS-PS) with a total score from 0 (no difficulty) to 100 (extreme difficulty)

  8. Function and pain [ Time Frame: 1 month after surgery ]
    Measured with the Oxford Knee Score (OKS) with a total score from 0 (most severe symptoms) to 48 (least severe symptoms)

  9. Quality of life [ Time Frame: 1 month after surgery ]
    Measured with the EuroQol-5D 3 level version (EQ-5D-3L) consisting of two scores: EQ Visual Analogue Scale (EQ VAS) score from 0 (worst imaginable health state) to 100 (best imaginable health state), and EQ-5D descriptive system (EQ-5D index).

  10. PainCoach app's perceived effectiveness [ Time Frame: Day 14 after surgery ]
    Usability, added value, and likelihood of being recommended to others was recorded on a 5-item scale ranging from totally agree to totally disagree

  11. Active PainCoach app use [ Time Frame: From day 1 to 14 after surgery ]
    Measured with recording the actual amount of app use and defining active use as at least 12 times in total


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Planned for primary TKR

Exclusion Criteria:

  • No possession of a smartphone or tablet
  • Contra-indication to any of the pain medication used in the study
  • No email address
  • No internet at home
  • No thorough command of the Dutch language
  • Suffering from memory disorders
  • Surgery under general anaesthesia
Contacts and Locations

Locations
Layout table for location information
Netherlands
Kliniek ViaSana
Mill, Netherlands
Sponsors and Collaborators
Kliniek ViaSana
St. Anna Ziekenhuis, Geldrop, Netherlands
Investigators
Layout table for investigator information
Principal Investigator: J.M. Brinkman, MD, PhD Kliniek ViaSana
Tracking Information
First Submitted Date  ICMJE May 14, 2019
First Posted Date  ICMJE May 23, 2019
Last Update Posted Date May 23, 2019
Actual Study Start Date  ICMJE January 15, 2016
Actual Primary Completion Date July 6, 2016   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 22, 2019)
  • Change in pain at rest in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Pain at rest was daily measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
  • Change in pain during activity in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
  • Change in pain at night in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
  • Change in opiate use in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Oxycodon (5 mg per tablet) use was recorded in quantities per 24 hours
Original Primary Outcome Measures  ICMJE Same as current
Change History No Changes Posted
Current Secondary Outcome Measures  ICMJE
 (submitted: May 22, 2019)
  • Pain at rest [ Time Frame: 1 month after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
  • Pain during activity [ Time Frame: 1 month after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
  • Pain at night [ Time Frame: 1 month after surgery ]
    Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
  • Change in other pain medication use in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    i.e. NSAID (Diclofenac), acetaminophen and/or Gabapentin were recorded in quantities per 24 hours
  • Change in pain acceptance at rest, during activity and at night in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14, and at 1 month after surgery ]
    Measured with a happy smiley (acceptable pain) and a sad smiley (unacceptable pain)
  • Change in experiences with the executed recommended physiotherapy exercises in the first two weeks at home after TKR [ Time Frame: 14 measurement points: daily from day 1 to 14 after surgery ]
    Measured on a 3-item scale; did too much, exactly enough, or could have done more exercises
  • Function [ Time Frame: 1 month after surgery ]
    Measured with the Knee injury and Osteoarthritis Outcome Score - Physical Function Short-form (KOOS-PS) with a total score from 0 (no difficulty) to 100 (extreme difficulty)
  • Function and pain [ Time Frame: 1 month after surgery ]
    Measured with the Oxford Knee Score (OKS) with a total score from 0 (most severe symptoms) to 48 (least severe symptoms)
  • Quality of life [ Time Frame: 1 month after surgery ]
    Measured with the EuroQol-5D 3 level version (EQ-5D-3L) consisting of two scores: EQ Visual Analogue Scale (EQ VAS) score from 0 (worst imaginable health state) to 100 (best imaginable health state), and EQ-5D descriptive system (EQ-5D index).
  • PainCoach app's perceived effectiveness [ Time Frame: Day 14 after surgery ]
    Usability, added value, and likelihood of being recommended to others was recorded on a 5-item scale ranging from totally agree to totally disagree
  • Active PainCoach app use [ Time Frame: From day 1 to 14 after surgery ]
    Measured with recording the actual amount of app use and defining active use as at least 12 times in total
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Effect of the PainCoach App on Pain and Opiate Use After Total Knee Replacement
Official Title  ICMJE Effect of the PainCoach App on Pain and Opiate Use in the First Two Weeks After Total Knee Replacement: Randomised Controlled Trial
Brief Summary

Less is known about pain and opiate use at home directly after total knee replacement (TKR). Regarding side effects, low opiate use is desired. An e-health application, PainCoach app, was developed to guide patients in pain control and opiate use.

The aim of this study was to investigate the effect of the PainCoach app on pain and opiate use in TKR patients in the first two weeks at home after surgery. The hypothesis was that the use of this app would decrease pain and opiate use.

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Patients were randomised to the PainCoach-app group or control group. Both groups received usual care. In the PainCoach-app group, in addition to receiving the aforementioned usual care, patients could use the PainCoach app whenever they wanted. In response to the patient's input of the pain experienced, the app gave advice on pain medication use, exercises/rest and when to call the clinic. This advice was the same as patients also received during usual care.
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Condition  ICMJE
  • Total Knee Replacement
  • Pain
  • Opioid Use
  • E-health App
Intervention  ICMJE Behavioral: PainCoach app
In response to the patient's input of the pain experienced (no pain, bearable pain, unbearable pain, or untenable pain), the app gave advice on pain medication use, exercises/rest and when to call the clinic from day 1 until day 14 after surgery.
Study Arms  ICMJE
  • Experimental: PainCoach-app group
    In the PainCoach-app group, in addition to receiving the aforementioned usual care, the PainCoach app was downloaded on each patient's smartphone or tablet. Patients could use this app whenever they wanted until day 14 after surgery. They were not subjected to any different treatment compared to the control group, i.e. advice on pain management was delivered in an extra and different way, but the pain medication itself was exactly the same for both groups.
    Intervention: Behavioral: PainCoach app
  • No Intervention: Control group
    The control group received usual care.
Publications * Pronk Y, Peters MCWM, Sheombar A, Brinkman JM. Effectiveness of a Mobile eHealth App in Guiding Patients in Pain Control and Opiate Use After Total Knee Replacement: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2020 Mar 13;8(3):e16415. doi: 10.2196/16415.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: May 22, 2019)
97
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE June 8, 2017
Actual Primary Completion Date July 6, 2016   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Planned for primary TKR

Exclusion Criteria:

  • No possession of a smartphone or tablet
  • Contra-indication to any of the pain medication used in the study
  • No email address
  • No internet at home
  • No thorough command of the Dutch language
  • Suffering from memory disorders
  • Surgery under general anaesthesia
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Netherlands
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03961152
Other Study ID Numbers  ICMJE PainCoach app study
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Kliniek ViaSana
Study Sponsor  ICMJE Kliniek ViaSana
Collaborators  ICMJE St. Anna Ziekenhuis, Geldrop, Netherlands
Investigators  ICMJE
Principal Investigator: J.M. Brinkman, MD, PhD Kliniek ViaSana
PRS Account Kliniek ViaSana
Verification Date May 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

治疗医院